drugset / Trial / NCT04926506

Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children

NCT04926506 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Any pathogen that causes an upper respiratory tract infection can cause bronchitis.The primary pathogen is virus. On the basis of virus infection, pathogenic bacteria may cause secondary infection or co-infection。Xiyanping injection is mainly used in the treatment of bronchitis by intravenous injection。

Timeline

Start
2021-10-08
Primary completion
2022-09-21
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Xiyanping injection Unknown 0.3 ml Intramuscular

Indications